Commonly reported side effects of dexmedetomidine include: bradycardia, hypotension, agitation, hypertension, nausea, and tachycardia. Other side effects include: vomiting, and xerostomia.  See below for a comprehensive list of adverse effects.
Side effects include:
Hypotension,   hypertension,  nausea,  bradycardia,   fever,   vomiting,   hypoxia,  tachycardia,  anemia. 
Very common (10% or more): Hypotension (56%), bradycardia (42%), systolic hypertension (28%), hypotension requiring intervention (28%), tachycardia (25%), hypertension requiring intervention (19%), hypertension (16%), diastolic hypertension (12%), tachycardia requiring intervention (10%)Common (1% to 10%): Atrial fibrillation, sinus tachycardia, myocardial ischemia or infarction, bradycardia requiring interventionUncommon (0.1% to 1%): Ventricular tachycardia, atrioventricular block first degree, decreased cardiac outputFrequency not reported: Sinus arrestPostmarketing reports: Arrhythmia, cardiac arrest, cardiac disorder, extrasystoles, supraventricular tachycardia, ventricular arrhythmia, electrocardiogram T wave inversion, prolonged QT, blood pressure fluctuation, heart block
Very common (10% or more): Respiratory depression (37%)Common (1% to 10%): Atelectasis, hypoxia, pulmonary edema, pleural effusion, respiratory failure, acute respiratory distress syndrome, bradypnea, pneumonia, pharyngolaryngeal painUncommon (0.1% to 1%): Wheezing, dyspnea, apneaFrequency not reported: Decreased respiratory ratePostmarketing reports: Bronchospasm, hypercapnia, hypoventilation, pulmonary congestion, respiratory acidosis
Very common (10% or more): Nausea (11%)Common (1% to 10%): Dry mouth, vomiting, constipation, abdominal distension, abdominal pain, diarrhea
Common (1% to 10%): Decubitus ulcerUncommon (0.1% to 1%): RashPostmarketing reports: Hyperhidrosis
Common (1% to 10%): AnemiaUncommon (0.1% to 1%): Thrombocytopenia
Common (1% to 10%): Hypovolemia, hyperglycemia, hypoglycemia, hypocalcemia, acidosis, hypokalemia, hypomagnesemia, hypernatremia, hypophosphatemiaUncommon (0.1% to 1%): Metabolic acidosis, hypoalbuminemia, electrolyte imbalancePostmarketing reports: Hyperkalemia, acidosis
Common (1% to 10%): HeadachePostmarketing reports: Convulsion, dizziness, neuralgia, neuritis, speech disorder
Common (1% to 10%): Pyrexia, hyperthermia, chills, post-procedural hemorrhage, withdrawal event/syndrome, rigors, hyperpyrexia, pain, thirst, generalized edema, peripheral edema, sepsis, septic shockUncommon (0.1% to 1%): Ineffective drugFrequency not reported: Tolerance, tachyphylaxisPostmarketing reports: Light anesthesia
Common (1% to 10%): Agitation, anxietyUncommon (0.1% to 1%): HallucinationPostmarketing reports: Confusional state, delirium, illusion
Common (1% to 10%): Acute renal failure, decreased urine output, oliguriaPostmarketing reports: Increased blood urea, polyuria
Postmarketing reports: Abnormal hepatic function, hyperbilirubinemia, increased ALT, increased AST, increased blood alkaline phosphatase, increased gamma-glutamyl transferase
Frequency not reported: Reduced lacrimationPostmarketing reports: Photopsia, abnormal vision, visual impairment